Traditional Chinese Medicine for Rapidly Progressing Early Puberty in Girls
Xuandi Ziyin Mixture
Diagnostic Study
Summary
Study start date: January 1, 2025
Actual date on which the first participant was enrolled.This study focuses on girls experiencing early puberty, particularly those with a rapidly progressing type. Researchers aim to see if two specific hormones, AMH and SHBG, are expressed differently before and after the diagnosis of rapid and slow progression types of early puberty. The goal is to determine if these differences can help predict which girls might experience rapid progression. The study also looks at how traditional Chinese medicine, specifically treatments that nourish yin and reduce fire, can be effective for these girls. Understanding these factors is important for developing better diagnosis and treatment guidelines for early puberty using traditional Chinese medicine. Participants in the study will receive traditional Chinese medicine treatments designed to nourish yin and reduce fire. The study will monitor changes in the expression of the hormones AMH and SHBG before and after treatment to evaluate the effectiveness of this approach. By comparing these hormone levels, researchers aim to assess whether this traditional medicine treatment has a therapeutic effect on girls with rapidly progressing early puberty. The study seeks to provide a standardized clinical basis for using traditional Chinese medicine in treating this condition.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.80 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 8 to 9 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Children's Hospital of Fudan University
Shanghai, ChinaOpen Children's Hospital of Fudan University in Google Maps